Substance abuse in schizophrenia: A review

Peter F. Buckley

Research output: Contribution to journalReview articlepeer-review

171 Scopus citations


Approximately half of the patients who suffer from schizophrenia are also substance abusers at some time during their illness. The motivational drive toward abusive consumption is compounded in individuals with schizophrenia who turn toward substances with reinforcing properties to alleviate aspects of psychosis. This review examines the prevalence, etiology, and clinical effects of substance abuse (e.g., alcohol, nicotine, cocaine) among individuals with schizophrenia. Clearly, substance abuse persists despite and in spite of treatment with typical antipsychotics. The efficacy of newer generation antipsychotics in the reduction of substance abuse among the schizophrenic population has yet to be established, but clozapine has been shown to reduce alcohol, smoking, and cocaine use. Hence, clozapine is a therapeutic option for dually diagnosed patients because of its superior efficacy relative to conventional neuroleptics and its capacity to control substance abuse.

Original languageEnglish (US)
Pages (from-to)26-30
Number of pages5
JournalJournal of Clinical Psychiatry
Issue numberSUPPL. 3
StatePublished - May 12 1998

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Substance abuse in schizophrenia: A review'. Together they form a unique fingerprint.

Cite this